Company Research
Whether you are exploring new sales opportunities or researching a new investment, FirstRain provides unique insight into important developments for Thermo Fisher Scientific Inc. (TMO). You can receive reports or configure the research engine for yourself.
Report On:
Thermo Fisher Scientific Inc. (TMO)
TECHNOLOGY - Electronics - Scientific & Technical Instruments
Generated: Thursday September 15, 2011 04:22 AM
|
|
||||||||||||||||||
Quotes About Thermo Fisher Scientific Inc.
-
Dry-Bags Make Light Work of Bulk Media Preparation
Our aim is to provide food microbiologists with products that enhance the efficiency of their laboratory,"
- Cheryl Mooney -
Ireland's First Fragment- Based Screening Programme
Combining the power of fragment-based drug discovery with our high-end instrumentation, we can effectively tackle our ever-expanding portfolio of therapeutic targets,"
- Neil Ferguson' -
CMC adds capacity at Denmark biologics site
We have worked closely with Thermo Fisher Scientific to bring this project in on time and on budget."
- Gustavo Mahler -
Analysis: Gene sequencers face govt budget squeeze
In the credit crisis of 2009, these stocks traded at a 10 percent discount to the S&P. So the relative valuation to the market can still come down,"
- Isaac Ro -
SUTIMCo International Inc. to Attend 125th AOAC Annual Meeting
Our presence at AOAC gives CapWave the opportunity to meet with prospective customers and introduce them to the Searchlight technology,"
- Ed Ellsworth
Latest Company Intelligence
-
Ex parte vs. inter partes: which is the dominant life form?
IPBiz | Sep 14,'11
In a post dated Sept. 13, 2011 at patents4life about the significant changes (and non-changes) introduced by HR 1249, one finds the text: 3. S. 302-307 – “Old” ex parte reexamination is not affected by Bill. (But, remember, ex parte reexamination is essentially unused now.) But in the weekly update of re-exams from InvnTree , ex parte outnumbered inter partes 2 to 1!! 1 -
Analysis: Gene sequencers face govt budget squeeze
Reuters | Sep 12,'11
| Mon Sep 12, 2011 3:13pm EDT (Reuters) - Companies that make the gene-sequencing devices used in scientific research face a tough few years as potential cuts to the U.S. federal budget squeeze funding to its main academic and research customers. -
Thermo Fisher cutting 122 jobs in N.H.
The BBJ's Morning Roundup - Bizjournals | Sep 9,'11
Waltham-based Thermo Fisher Scientific Inc. is cutting 122 jobs in New Hampshire in a move to “increase efficiencies” and “improve competitiveness,” Mass High Tech reports, citing a company spokesperson. The positions -- in its equipment manufacturing site and its assembly facility -- will move to sites to sites in North Carolina and Ohio, MHT reports. See all your followed company -
Thermo Fisher moving jobs out of NH
Canadian Business Online | Sep 8,'11
NEWINGTON, N.H. (AP) — A maker of laboratory equipment has announced plans to move more than 100 jobs out of New Hampshire. Thermo Fisher Scientific (http://bit.ly/p2nmOP) announced Wednesday that it will transfer operations at its Newington facility to Asheville, N.C., a move that will eliminate 109 local manufacturing jobs. In a separate move, the company also told 13 employees at -
Thermo Fisher Scientific Opens New Biomarker Translational Center
PR inside | Sep 7,'11
2011-09-07 15:29:51 - Goal is to Accelerate Mass Spectrometry-based Biomarker Discovery and its Translation into Development of Routine Clinical Assays GENEVA, Switzerland (September 6, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced at the Human Proteome Organization (HUPO) 2011 World Congress the establishment of a new Biomarker Translational -
M&A
Fortune Finance - CNNMoney.com | Aug 29,'11
Alpha Bank and Eurobank, a pair of Greek lenders, have agreed to merge. The deal is expected to close by year-end, pending regulatory approval. AuRico Gold has agreed to acquire Canadian gold mining company Northgate Minerals for C$1.46 billion, or C$5.01 per share. Thermo-Fisher Scientific (NYSE: TMO) has completed its acquisition of Phadia AB, an allergy-testing company, from
FirstRain customers use intelligent business search to find actionable insights about companies, management, and industries. You can review company briefs, quickly research a new idea or opportunity, generate personalized industry reports, or set up alerts on reasons to call. Be sure to view our sample reports below.
